GASTROINTESTINAL TRACT INFECTIONS

exp date isn't null, but text field is

Acute gastroenteritis

Infection/Condition and Likely Organism

Suggested Treatment

Comments

Preferred Treatment

Alternative Treatment

Acute gastroenteritis

Usually viruses e.g. rotavirus

Antibiotics not recommended

Oral rehydration is the cornerstone of treatment. Antibiotic therapy may prolong carriage state of salmonellosis.

Dysentery

Infection/Condition and Likely Organism

Suggested Treatment

Comments

Preferred Treatment

Alternative Treatment

Dysentery

Shigella spp., Escherichia coli, Campylobacter

Most are mild infections which resolve spontaneously without antibiotics

 

 

Mild or uncomplicated

No treatment required

Ampicillin 100mg/kg/day PO in 4 divided doses for 5-7 days for hospitalized children

Amoxicillin, Trimethoprim-sulfamethoxazole, Ciprofloxacin and Azithromycin resistance are in the rise.

Duration : 3 days.

For immunocompromised : 7-10 days.

Reserve fluoroquinolone only for isolate where there is no other antibiotic option.

Severe illness (hospitalisation, invasive or other complications) or immunocompromised

patients

Empiric: Ceftriaxone 50-75mg/kg/day IV q24h for 5 days

Ciprofloxacin 20-30mg/kg/day IV in 2 divided doses for 3 days

OR

Azithromycin 10mg/kg/dose IV q24h (max. 500mg/dose)

Dysentery Amoebiasis

Metronidazole 30-50mg/kg/day PO in 3 divided doses for 7-10 days

 

Similar dosage for extraintestinal disease.

Giardiasis

Metronidazole 15mg/kg/day PO (max. 250mg) in 3 divided doses for 5-7 days

 

 

Hospital acquired diarrhea

Clostridium difficile

Metronidazole 30mg/kg/day PO in 4 divided doses for 10 days

In severe diseases

Vancomycin 40mg/kg/day PO in 4 divided doses for 10 days

PLUS

Metronidazole 30mg/kg/day PO in 4 divided doses for 10 days

 

Typhoid Fever

Infection/Condition and Likely Organism

Suggested Treatment

Comments

Preferred Treatment

Alternative Treatment

Typhoid fever

Salmonella Typhi

Salmonella Paratyphi A and B

Empirical treatment: Ceftriaxone 50-75mg/kg/day IV q24h (max. 2gm) for 7-14 days

OR

Azithromycin 20mg/kg/day (1g/day) for 7 days

 

Adjust antibiotic once C&S results are known.

Duration of antibiotics: 7 days (uncomplicated) to 14 days (severe disease or if using Ampicillin or Trimethoprim-sulfamethoxazole).

Mild or uncomplicated

Azithromycin 20mg/kg/day (1g/day) for 7 days

OR

Ciprofloxacin 20-40mg/kg/day (max. 1.5gm per day) PO in 2 divided doses for 5-7 days

OR

Cefixime 20mg/kg/day in 2 divided doses for 7 days

Chloramphenicol 50-100mg/kg/day PO in 4 divided doses for minimum 14 days

Severe infection or suspected resistant organism

Ceftriaxone 60-80mg/kg/day IV q24h for 7-14 days

Ciprofloxacin 20-30mg/kg/day IV (max. 0.8-1.2gm/day) in 2 divided doses for 7-10 days

Choice of antibiotics and duration depends on disease, C&S results and whether oral route is preferred.

Fluoroquinolones need to be used with caution in children due to possible arthropathy and rapid development of resistance. Ampicillin and Trimethoprim-sulfamethoxazole may be considered for susceptible strain.

Chronic carrier state (> 1 year)

Ampicillin 100mg/kg/day PO in 4 divided doses for 6 weeks

OR

Amoxicillin 100mg/kg/day PO in 2 divided doses for 6 weeks

OR

Trimethoprim-sulfamethoxazole  8mg (TMP)/kg/day PO in two divided doses for 6 weeks

Ciprofloxacin 20-30mg/kg/day PO in 2 divided doses for 4 weeks.

OR

Ampicillin 200-300mg/kg/day IV maximum in 4-6 divided doses. (If oral therapy not tolerated and strain is susceptible)

Cholera

Infection/Condition and Likely Organism

Suggested Treatment

Comments

Preferred Treatment

Alternative Treatment

Cholera

Vibrio cholerae

Azithromycin 20mg/kg/ day PO in a single dose (max. 1gm)

OR

Erythromycin ethylsuccinate 12.5mg/ kg/dose PO q6h for 3 days (max. 250mg/dose)

(Watch group preferred due to lesser adverse effects)

Doxycycline 4.4mg/kg/ day (max. 200mg/day) PO daily (children> 8 years old)

OR

Tetracycline 12.5mg/kg/ dose PO in q6h (max. 500mg/dose) for 3 days (children > 8 years old)

Oral or IV rehydration is the cornerstone of treatment. Antimicrobials should be considered for moderately to severely ill.

Avoid using Tetracycline or Doxycycline for young children.

Use of Doxycycline should be considered in an epidemic caused by susceptible isolate.

Fluoroquinolones - not approved for children < 18 years for this indication.

Liver abscess

Infection/Condition and Likely Organism

Suggested Treatment

Comments

Preferred Treatment

Alternative Treatment

Liver abscess (amoebic) Entamoeba histolytica

Metronidazole 35-50mg/ kg/day PO in 3 divided doses for 7-10 days

 

Amoebic abscess tends to be solitary lesion. Consider surgical drainage if needed.

Liver abscess (pyogenic). Klebsiella spp., Escherichia coli, Streptococcus, anginosus group, other Gram-negative organisms, anaerobes, Staphylococcus aureus

Cefotaxime 200mg-300mg/kg/day IV in 4 divided doses (max. 2gm/ dose)

OR

Ceftriaxone 100mg/kg/ day IV in 1-2 divided doses (max. 2gm/dose; 4gm/ day)

PLUS

Metronidazole 22.5-40mg/kg/day IV in 3 divided doses max. 4 mg/day

Piperacillin-tazobactam 300mg/kg/day (of piperacillin component) IV in 3-4 divided doses (max. 16gm/day)

ESBL-Klebsiella spp. Ertapenem 30mg/kg/day in 2 divided doses (max. 1gm/day) (above 3 months of age)*

Surgical drainage is needed in most cases. Duration: 4-6 weeks

*If available

Acute Cholangitis

Infection/Condition and Likely Organism

Suggested Treatment

Comments

Preferred Treatment

Alternative Treatment

Acute cholangitis

Gram-positive and Gram-negative organisms, anaerobes

Ampicillin-sulbactam 200-300mg/kg/day (of Ampicillin component) IV in 4-6 equally-divided doses

Cefotaxime 200mg-300mg/kg IV in 4 divided doses (max. 2gm/dose)

OR

Ceftriaxone 100mg/kg/ day IV in 1-2 divided doses (max. 2gm/dose; 4gm/ day)  PLUS

Metronidazole 22.5-40mg/kg/day IV in 3 divided doses (max. 4gm/day)

OR

Piperacillin-tazobactam 300mg/kg/day (of piperacillin component) in 3-4 divided doses IV (max. 16gm/day)

Duration - 7 days. Outcome is similar with less than 7 days to those with longer duration >7 days in patients treated with percutaneous cholecystectomy. In treatment failure, need source control.

Peritonitis

Infection/Condition and Likely Organism

Suggested Treatment

Comments

Preferred Treatment

Alternative Treatment

Peritonitis

Gram-positive and Gram-negative organisms, anaerobes

Primary/spontaneous bacterial peritonitis

Cefotaxime 200mg -300mg/kg IV in 4 divided doses (max. 2gm/dose)

Secondary (nosocomial) peritonitis Piperacillin-tazobactam IV 300mg/kg/day in 3- 4 divided doses (max. 16gm/day)

Ampicillin 100mg/kg/day PO in 4 divided doses

PLUS

Gentamicin 5mg/kg/day IV q24h

PLUS

Metronidazole 7.5mg/kg/ dose IV 8h for 7-14 days

May omit Metronidazole in primary peritonitis.

In immunocompetent patient with mild to moderate peritonitis and source control, suggest 5 days of therapy.

 

If culture proven ESBL:

Imipenem-cilastatin 60-100mg/kg/day IV in 4 divided doses

Meropenem 60-100mg/kg/day IV in 3 divided doses

 

De-escalate treatment to Ertapenem 30mg/kg/day IV in 2 divided doses (max. 1gm/day) once patient is stable.

References
  1. American Academy of Paediatrics. Committee on Infectious Diseases. Red Book: Report of the Committee on Infectious Diseases (2018).
  2. Antibiotics Resistance Threats in the United States 2013.
  3. Phoebe Williams, Prof James A Berkeley. Dysentery (Shigellosis) Current WHO Guidelines and the WHO Essential Medicine List for Children. November 2016.
  4. National Antimicrobial Guideline, Third Edition. Petaling Jaya: Ministry of Health, Malaysia; 2019
  5. Patrick Mosler. Management of Acute Cholangitis. Gasteroenterol Hepato (NY) 2011 Feb; 7(2): 121-123.
  6. Solomkin JS, Mazuski JE, Bradley JS, et al.; Surgical Infection Society; Infectious Diseases Society of America. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(2):135.
  7. WHO/CDD/SER/91.15 REV.1. Management of Patient with Cholera.
  8. WHO/VandB/03-07 (2003) Background document: the diagnosis, treatment and prevention of typhoid fever.